One-to-many propensity score matching in cohort studies
- PMID: 22552982
- DOI: 10.1002/pds.3263
One-to-many propensity score matching in cohort studies
Abstract
Background: Among the large number of cohort studies that employ propensity score matching, most match patients 1:1. Increasing the matching ratio is thought to improve precision but may come with a trade-off with respect to bias.
Objective: To evaluate several methods of propensity score matching in cohort studies through simulation and empirical analyses.
Methods: We simulated cohorts of 20,000 patients with exposure prevalence of 10%-50%. We simulated five dichotomous and five continuous confounders. We estimated propensity scores and matched using digit-based greedy ("greedy"), pairwise nearest neighbor within a caliper ("nearest neighbor"), and a nearest neighbor approach that sought to balance the scores of the comparison patient above and below that of the treated patient ("balanced nearest neighbor"). We matched at both fixed and variable matching ratios and also evaluated sequential and parallel schemes for the order of formation of 1:n match groups. We then applied this same approach to two cohorts of patients drawn from administrative claims data.
Results: Increasing the match ratio beyond 1:1 generally resulted in somewhat higher bias. It also resulted in lower variance with variable ratio matching but higher variance with fixed. The parallel approach generally resulted in higher mean squared error but lower bias than the sequential approach. Variable ratio, parallel, balanced nearest neighbor matching generally yielded the lowest bias and mean squared error.
Conclusions: 1:n matching can be used to increase precision in cohort studies. We recommend a variable ratio, parallel, balanced 1:n, nearest neighbor approach that increases precision over 1:1 matching at a small cost in bias.
Copyright © 2012 John Wiley & Sons, Ltd.
Similar articles
-
An application of propensity score matching using claims data.Pharmacoepidemiol Drug Saf. 2005 Jul;14(7):465-76. doi: 10.1002/pds.1062. Pharmacoepidemiol Drug Saf. 2005. PMID: 15651087
-
Use of propensity score technique to account for exposure-related covariates: an example and lesson.Med Care. 2007 Oct;45(10 Supl 2):S143-8. doi: 10.1097/MLR.0b013e318074ce79. Med Care. 2007. PMID: 17909373
-
Matching by propensity score in cohort studies with three treatment groups.Epidemiology. 2013 May;24(3):401-9. doi: 10.1097/EDE.0b013e318289dedf. Epidemiology. 2013. PMID: 23532053
-
A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003.Stat Med. 2008 May 30;27(12):2037-49. doi: 10.1002/sim.3150. Stat Med. 2008. PMID: 18038446 Review.
-
An overview of the objectives of and the approaches to propensity score analyses.Eur Heart J. 2011 Jul;32(14):1704-8. doi: 10.1093/eurheartj/ehr031. Epub 2011 Feb 28. Eur Heart J. 2011. PMID: 21362706 Review.
Cited by
-
Investigating the peri-saphenous vein graft fat attenuation index on computed tomography angiography: relationship with progression of venous coronary artery bypass graft disease and temporal trends.BMC Cardiovasc Disord. 2024 Oct 26;24(1):597. doi: 10.1186/s12872-024-04257-4. BMC Cardiovasc Disord. 2024. PMID: 39462356 Free PMC article.
-
Frailty as a sequela of burn injury: a post hoc analysis of the "RE-ENERGIZE" multicenter randomized-controlled trial and the National Health Interview Survey.Mil Med Res. 2024 Sep 12;11(1):63. doi: 10.1186/s40779-024-00568-x. Mil Med Res. 2024. PMID: 39267196 Free PMC article. Clinical Trial.
-
The association between comprehensive medication review and medication adherence among medicare beneficiaries with chronic obstructive pulmonary disease.Explor Res Clin Soc Pharm. 2024 Jun 24;15:100470. doi: 10.1016/j.rcsop.2024.100470. eCollection 2024 Sep. Explor Res Clin Soc Pharm. 2024. PMID: 39050144 Free PMC article.
-
Lazertinib versus Platinum-Based Chemotherapy with Epidermal Growth Factor Receptor (EGFR)-Positive Non-Small-Cell Lung Cancer after Failing EGFR-Tyrosine Kinase Inhibitor: A Real-World External Comparator Study.Cancers (Basel). 2024 Jun 7;16(12):2169. doi: 10.3390/cancers16122169. Cancers (Basel). 2024. PMID: 38927875 Free PMC article.
-
Health Care Utilization and Costs Associated With Empagliflozin in Older Adults With Type 2 Diabetes.Diabetes Care. 2024 Nov 1;47(11):1900-1907. doi: 10.2337/dc24-0270. Diabetes Care. 2024. PMID: 38917305
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
